The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Inflammatory Bowel Disease

Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease

Inflamm Bowel Dis.

Hirten RP, Grinspan A, Fu SC, Luo Y, Suarez-Farinas M, Rowland J, Contijoch EJ, Mogno I, Yang N, Luong T, Labrias PR, Peter I, Cho JH, Sands BE, Colombel JF, Faith JJ, Clemente JC

doi: 10.1093/ibd/izy398.

Inflammatory Bowel Disease

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

Gut.

Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H, IBD guidelines eDelphi consensus group., Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB

doi: 10.1136/gutjnl-2019-318484.

Gastrointestinal Cancer

Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease

Clin Gastroenterol Hepatol.

Vaughn BP, Rank KM, Khoruts A

doi: 10.1016/j.cgh.2018.07.026.

Inflammatory Bowel Disease

Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)

Eur J Clin Microbiol Infect Dis.

Vehreschild MJGT, Taori S, Goldenberg SD, Thalhammer F, Bouza E, van Oene J, Wetherill G, Georgopali A

doi: 10.1007/s10096-018-3344-1.

Helicobacter Pylori

Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection

Am J Gastroenterol.

Kumar S, Metz DC, Kaplan DE, Goldberg DS

doi: 10.14309/ajg.0000000000000626.

Hepatology

Fecal Microbiota Transplantation is Safe and Effective in Patients with Clostridioides difficile Infection and Cirrhosis

Clin Gastroenterol Hepatol.

Cheng YW, Alhaffar D, Saha S, Khanna S, Bohm M, Phelps E, Ghabril M, Orman E, Sashidhar S, Rogers N, Xu H, Khoruts A, Vaughn B, Kao D, Wong K, Cammarota G, Ianiro G, Dhere T, Kraft CS, Mehta N, Michael Woodworth H, Allegretti JR, Nativ L, Marcus J, El-Nachef N, Fischer M

doi: 10.1016/j.cgh.2020.06.051.

Further Publications

European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus

United European Gastroenterol J

Hammer HF, Fox MR, Keller J, Salvatore S, Basilisco G, Hammer J, Lopetuso L, Benninga M, Borrelli O, Dumitrascu D, Hauser B, Herszenyi L, Nakov R, Pohl D, Thapar N, Sonyi M, European H2-CH4-breath test group.

doi: 10.1002/ueg2.12133

Irritable Bowel Syndrome (IBS) and Chronic Constipation

British Society of Gastroenterology guidelines on the management of irritable bowel syndrome

Gut

Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Corsetti M, Agrawal A, Aziz I, Farmer AD, Eugenicos MP, Moss-Morris R, Yiannakou Y, Ford AC

doi: 10.1136/gutjnl-2021-324598

Inflammatory Bowel Disease

Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial

Inflamm Bowel Dis.

Gawronska A, Banasiuk M, Lachowicz D, Pituch H, Albrecht P, Banaszkiewicz A

doi: 10.1097/

Related content

Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease

Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)

Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection

Fecal Microbiota Transplantation is Safe and Effective in Patients with Clostridioides difficile Infection and Cirrhosis

British Society of Gastroenterology guidelines on the management of irritable bowel syndrome

Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial